Literature DB >> 18486811

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

Sundeep Khosla, David Burr, Jane Cauley, David W Dempster, Peter R Ebeling, Dieter Felsenberg, Robert F Gagel, Vincente Gilsanz, Theresa Guise, Sreenivas Koka, Laurie K McCauley, Joan McGowan, Marc D McKee, Suresh Mohla, David G Pendrys, Lawrence G Raisz, Salvatore L Ruggiero, David M Shafer, Lillian Shum, Stuart L Silverman, Catherine H Van Poznak, Nelson Watts, Sook-Bin Woo, Elizabeth Shane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18486811     DOI： 10.1016/j.joms.2008.01.054

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  11 in total

Review 1.  Bone Density Screening and Re-screening in Postmenopausal Women and Older Men.

Authors:  Margaret L Gourlay; Robert A Overman; Kristine E Ensrud
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

2.  OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.

Authors:  Rafael Scaf de Molon; Hiroaki Shimamoto; Olga Bezouglaia; Flavia Q Pirih; Sarah M Dry; Paul Kostenuik; Rogely W Boyce; Denise Dwyer; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2015-05-27       Impact factor: 6.741

3.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

Review 4.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

5.  Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws.

Authors:  Y-D Kwon; D-W Lee; B-J Choi; J-W Lee; D-Y Kim
Journal:  Osteoporos Int       Date:  2012-01-05       Impact factor: 4.507

6.  Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.

Authors:  Valesca S Koth; Maria A Figueiredo; Fernanda G Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2017-02-17       Impact factor: 2.419

Review 7.  Serum C-terminal cross-linking telopeptide level as a predictive biomarker of osteonecrosis after dentoalveolar surgery in patients receiving bisphosphonate therapy: Systematic review and meta-analysis.

Authors:  Mohamed E Awad; Christina Sun; Joshua Jernigan; Mohammed Elsalanty
Journal:  J Am Dent Assoc       Date:  2019-06-28       Impact factor: 3.634

8.  Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.

Authors:  Vivek Thumbigere-Math; Bryan S Michalowicz; Pamela J Hughes; David L Basi; Michaela L Tsai; Karen K Swenson; Laura Rockwell; Rajaram Gopalakrishnan
Journal:  J Oral Maxillofac Surg       Date:  2015-10-03       Impact factor: 1.895

9.  The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.

Authors:  Athanassios Kyrgidis; Thrasivoulos-George Tzellos; Konstantinos Toulis; Konstantinos Antoniades
Journal:  J Osteoporos       Date:  2011-02-16

10.  Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ).

Authors:  Hyo-Won Jang; Jin-Woo Kim; In-Ho Cha
Journal:  Maxillofac Plast Reconstr Surg       Date:  2015-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.